196 related articles for article (PubMed ID: 33230924)
21. Planned delivery or expectant management for late preterm pre-eclampsia: study protocol for a randomised controlled trial (PHOENIX trial).
Chappell LC; Green M; Marlow N; Sandall J; Hunter R; Robson S; Bowler U; Chiocchia V; Hardy P; Juszczak E; Linsell L; Placzek A; Brocklehurst P; Shennan A
Trials; 2019 Jan; 20(1):85. PubMed ID: 30691508
[TBL] [Abstract][Full Text] [Related]
22. Role of proteinuria in defining pre-eclampsia: clinical outcomes for women and babies.
Thornton CE; Makris A; Ogle RF; Tooher JM; Hennessy A
Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):466-70. PubMed ID: 19930427
[TBL] [Abstract][Full Text] [Related]
23. Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study.
Hawkins TL; Roberts JM; Mangos GJ; Davis GK; Roberts LM; Brown MA
BJOG; 2012 Mar; 119(4):484-92. PubMed ID: 22251368
[TBL] [Abstract][Full Text] [Related]
24. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial.
Broekhuijsen K; van Baaren GJ; van Pampus MG; Ganzevoort W; Sikkema JM; Woiski MD; Oudijk MA; Bloemenkamp KW; Scheepers HC; Bremer HA; Rijnders RJ; van Loon AJ; Perquin DA; Sporken JM; Papatsonis DN; van Huizen ME; Vredevoogd CB; Brons JT; Kaplan M; van Kaam AH; Groen H; Porath MM; van den Berg PP; Mol BW; Franssen MT; Langenveld J;
Lancet; 2015 Jun; 385(9986):2492-501. PubMed ID: 25817374
[TBL] [Abstract][Full Text] [Related]
25. Blood pressure thresholds in pregnancy for identifying maternal and infant risk: a secondary analysis of Community-Level Interventions for Pre-eclampsia (CLIP) trial data.
Bone JN; Magee LA; Singer J; Nathan H; Qureshi RN; Sacoor C; Sevene E; Shennan A; Bellad MB; Goudar SS; Mallapur AA; Munguambe K; Vidler M; Bhutta ZA; von Dadelszen P;
Lancet Glob Health; 2021 Aug; 9(8):e1119-e1128. PubMed ID: 34237265
[TBL] [Abstract][Full Text] [Related]
26. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial.
Koopmans CM; Bijlenga D; Groen H; Vijgen SM; Aarnoudse JG; Bekedam DJ; van den Berg PP; de Boer K; Burggraaff JM; Bloemenkamp KW; Drogtrop AP; Franx A; de Groot CJ; Huisjes AJ; Kwee A; van Loon AJ; Lub A; Papatsonis DN; van der Post JA; Roumen FJ; Scheepers HC; Willekes C; Mol BW; van Pampus MG;
Lancet; 2009 Sep; 374(9694):979-988. PubMed ID: 19656558
[TBL] [Abstract][Full Text] [Related]
27. Early warning system hypertension thresholds to predict adverse outcomes in pre-eclampsia: A prospective cohort study.
Nathan HL; Seed PT; Hezelgrave NL; De Greeff A; Lawley E; Anthony J; Hall DR; Steyn W; Chappell LC; Shennan AH
Pregnancy Hypertens; 2018 Apr; 12():183-188. PubMed ID: 29175171
[TBL] [Abstract][Full Text] [Related]
28. Perinatal outcomes after hypertensive disorders in pregnancy in a low resource setting.
Browne JL; Vissers KM; Antwi E; Srofenyoh EK; Van der Linden EL; Agyepong IA; Grobbee DE; Klipstein-Grobusch K
Trop Med Int Health; 2015 Dec; 20(12):1778-86. PubMed ID: 26426071
[TBL] [Abstract][Full Text] [Related]
29. Perinatal outcomes in women with elevated blood pressure and stage 1 hypertension.
Greenberg VR; Silasi M; Lundsberg LS; Culhane JF; Reddy UM; Partridge C; Lipkind HS
Am J Obstet Gynecol; 2021 May; 224(5):521.e1-521.e11. PubMed ID: 33157064
[TBL] [Abstract][Full Text] [Related]
30. Mid-trimester uterine artery Doppler screening as a predictor of adverse pregnancy outcome in high-risk women.
Coleman MA; McCowan LM; North RA
Ultrasound Obstet Gynecol; 2000 Jan; 15(1):7-12. PubMed ID: 10776006
[TBL] [Abstract][Full Text] [Related]
31. Term small-for-gestational-age infants from low-risk women are at significantly greater risk of adverse neonatal outcomes.
Madden JV; Flatley CJ; Kumar S
Am J Obstet Gynecol; 2018 May; 218(5):525.e1-525.e9. PubMed ID: 29462628
[TBL] [Abstract][Full Text] [Related]
32. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis.
Brocklehurst P; French R
Br J Obstet Gynaecol; 1998 Aug; 105(8):836-48. PubMed ID: 9746375
[TBL] [Abstract][Full Text] [Related]
33. Association of proteinuria threshold in pre-eclampsia with maternal and perinatal outcomes: a nested case control cohort of high risk women.
Bramham K; Poli-de-Figueiredo CE; Seed PT; Briley AL; Poston L; Shennan AH; Chappell LC
PLoS One; 2013; 8(10):e76083. PubMed ID: 24130760
[TBL] [Abstract][Full Text] [Related]
34. Are blood pressure level and variability related to pregnancy outcome? Analysis of control of hypertension in pregnancy study data.
Magee LA; Singer J; Lee T; McManus RJ; Lay-Flurrie S; Rey E; Chappell LC; Myers J; Logan AG; von Dadelszen P
Pregnancy Hypertens; 2020 Jan; 19():87-93. PubMed ID: 31927325
[TBL] [Abstract][Full Text] [Related]
35. Predicting delivery of a small-for-gestational-age infant and adverse perinatal outcome in women with suspected pre-eclampsia.
Griffin M; Seed PT; Duckworth S; North R; Myers J; Mackillop L; Simpson N; Waugh J; Anumba D; Kenny LC; Redman CWG; Shennan AH; Chappell LC
Ultrasound Obstet Gynecol; 2018 Mar; 51(3):387-395. PubMed ID: 28401605
[TBL] [Abstract][Full Text] [Related]
36. Effect of simple, targeted diet in pregnant women with metabolic risk factors on maternal and fetal outcomes (ESTEEM): study protocol for a pragmatic multicentre randomised trial.
Al Wattar BH; Dodds J; Placzek A; Spyreli E; Moore A; Hooper R; Beresford L; Roseboom TJ; Bes-Rastrollo M; Hitman G; Khan KS; Thangaratinam S;
BMJ Open; 2016 Oct; 6(10):e013495. PubMed ID: 27798035
[TBL] [Abstract][Full Text] [Related]
37. The predictive value of signs and symptoms in predicting adverse maternal and perinatal outcomes in severe preeclampsia in a low-resource setting, findings from a cross-sectional study at Mpilo Central Hospital, Bulawayo, Zimbabwe.
Ngwenya S; Jones B; Mwembe D; Nare H; Heazell A
Pregnancy Hypertens; 2020 Jul; 21():77-83. PubMed ID: 32450422
[TBL] [Abstract][Full Text] [Related]
38. Prediction of adverse outcomes by common definitions of hypertension in pregnancy.
Zhang J; Klebanoff MA; Roberts JM
Obstet Gynecol; 2001 Feb; 97(2):261-7. PubMed ID: 11165592
[TBL] [Abstract][Full Text] [Related]
39. Serious perinatal complications of non-proteinuric hypertension: an international, multicentre, retrospective cohort study.
Magee LA; von Dadelszen P; Bohun CM; Rey E; El-Zibdeh M; Stalker S; Ross S; Hewson S; Logan AG; Ohlsson A; Naeem T; Thornton JG; Abdalla M; Walkinshaw S; Brown M; Davis G; Hannah ME
J Obstet Gynaecol Can; 2003 May; 25(5):372-82. PubMed ID: 12738978
[TBL] [Abstract][Full Text] [Related]
40. World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre-eclampsia in populations of low nutritional status from developing countries.
Villar J; Purwar M; Merialdi M; Zavaleta N; Thi Nhu Ngoc N; Anthony J; De Greeff A; Poston L; Shennan A;
BJOG; 2009 May; 116(6):780-8. PubMed ID: 19432566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
